Literature DB >> 6336943

Human hybridomas from patients with malignant disease.

K Sikora, T Alderson, J Ellis, J Phillips, J Watson.   

Abstract

Lymphocytes from 180 patients with a variety of malignant diseases were collected and fused with a human myeloma-derived line, LON-LICR-HMy2/CAM1. A total of 162 hybridomas was obtained. Only B lymphocyte markers were found on the surface of the fusion products. Flow cytometric analysis revealed a stably increased DNA content in the hybridoma cells. Some hybridoma supernatants were found to contain new Ig chains. Anti-tumour binding activity was found in 12 supernatants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336943      PMCID: PMC2011244          DOI: 10.1038/bjc.1983.16

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Mouse-human hybridomas. The conversion of non-secreting human B cells into Ig secretors.

Authors:  R Levy; J Dilley; K Sikora; R Kucherlapati
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

2.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

3.  Production of human hybridomas secreting antibodies to measles virus.

Authors:  C M Croce; A Linnenbach; W Hall; Z Steplewski; H Koprowski
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

4.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.

Authors:  L Olsson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Human monoclonal antibody against Forssman antigen.

Authors:  R Nowinski; C Berglund; J Lane; M Lostrom; I Bernstein; W Young; S I Hakomori; L Hill; M Cooney
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728

6.  A procedure for the fusion of cells in suspension by means of polyethylene glycol.

Authors:  A Hales
Journal:  Somatic Cell Genet       Date:  1977-03

7.  Pattern of immunoglobulin synthesis and assembly in a human-mouse somatic cell hybrid clone.

Authors:  J Schwaber; E P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

8.  Pluripotent teratocarcinoma-thymus somatic cell hybrids.

Authors:  R A Miller; F H Ruddle
Journal:  Cell       Date:  1976-09       Impact factor: 41.582

9.  Generation of human monoclonal antibodies reactive with human mammary carcinoma cells.

Authors:  J Schlom; D Wunderlich; Y A Teramoto
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  18 in total

1.  Generating human monoclonal antibodies.

Authors:  A M Neville; P A Edwards; M J O'Hare
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

Review 2.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

3.  Detection of lymphocytes in malignant gliomas by monoclonal antibodies.

Authors:  K Yasuda; T Alderson; J Phillips; K Sikora
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

Review 4.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

Review 5.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 6.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

7.  Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.

Authors:  C J Punt; J A Barbuto; H Zhang; W J Grimes; K D Hatch; E M Hersh
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

8.  Tumour localisation by human monoclonal antibodies.

Authors:  K Sikora; T Alderson; A Nethersell; H Smedley
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

9.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

10.  A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice.

Authors:  L Dazord; D Bourel; A Martin; R Lecorre; P Bourguet; J Bohy; J C Saccavini; P Delaval; M Louvet; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.